{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:27:41Z","timestamp":1786595261639,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203605"],"award-info":[{"award-number":["82203605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072762"],"award-info":[{"award-number":["82072762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M701610"],"award-info":[{"award-number":["2021M701610"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08397-3","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:16:16Z","timestamp":1780910176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FAM135B suppresses glioblastoma angiogenesis via stabilizing the IKK complex and inactivating the NF-\u03baB\/IL-6 signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Chuangyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenya","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuozhou","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-8559","authenticated-orcid":false,"given":"Yiquan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9802-8065","authenticated-orcid":false,"given":"Zetao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8397_CR1","doi-asserted-by":"crossref","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults. JAMA. 2023:329.","DOI":"10.1001\/jama.2023.0023"},{"key":"8397_CR2","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/S1470-2045(19)30796-X","volume":"21","author":"TS Armstrong","year":"2020","unstructured":"Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, et al. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report. Lancet Oncol. 2020;21:e97\u2013103.","journal-title":"Lancet Oncol"},{"key":"8397_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2023.02.019","volume":"41","author":"Y Hoogstrate","year":"2023","unstructured":"Hoogstrate Y, Draaisma K, Ghisai SA, van Hijfte L, Barin N, de Heer I, et al. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell. 2023;41:678\u2013e692677.","journal-title":"Cancer Cell"},{"key":"8397_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14712598.3.4.551","volume":"3","author":"T Visted","year":"2005","unstructured":"Visted T, Lund-Johansen M. Progress and challenges for cell encapsulation in brain tumor therapy. Expert Opin Biol Ther. 2005;3:551\u201361.","journal-title":"Expert Opin Biol Ther"},{"key":"8397_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy. Science. 2005;307:58\u201362.","journal-title":"Science"},{"key":"8397_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, et al. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma. N Engl J Med. 2014;370:699\u2013708.","journal-title":"N Engl J Med"},{"key":"8397_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, et al. Bevacizumab plus Radiotherapy\u2013Temozolomide for Newly Diagnosed Glioblastoma. N Engl J Med. 2014;370:709\u201322.","journal-title":"N Engl J Med"},{"key":"8397_CR8","doi-asserted-by":"crossref","unstructured":"Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M. Anti-angiogenic therapy for high-grade glioma. Cochrane Database Syst Rev 2018. 2018.","DOI":"10.1002\/14651858.CD008218.pub4"},{"key":"8397_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/0008-5472.CAN-20-0912","volume":"81","author":"D Dong","year":"2021","unstructured":"Dong D, Zhang W, Xiao W, Wu Q, Cao Y, Gao X, et al. A GRN Autocrine-Dependent FAM135B\/AKT\/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression. Cancer Res. 2021;81:910\u201322.","journal-title":"Cancer Res"},{"key":"8397_CR10","doi-asserted-by":"crossref","unstructured":"Zhang K, Wu Q, Liu W, Wang Y, Zhao L, Chen J, et al. FAM135B sustains the reservoir of Tip60-ATM assembly to promote DNA damage response. Clin Transl Med. 2022:12.","DOI":"10.1002\/ctm2.945"},{"key":"8397_CR11","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1038\/s41388-024-03189-9","volume":"43","author":"W Lin","year":"2024","unstructured":"Lin W, Xu L, Li Y, Li J, Zhao L. Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing. Oncogene. 2024;43:3532\u201344.","journal-title":"Oncogene"},{"key":"8397_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","volume":"187","author":"R Mathur","year":"2024","unstructured":"Mathur R, Wang Q, Schupp PG, Nikolic A, Hilz S, Hong C, et al. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective. Cell. 2024;187:446\u2013e463416.","journal-title":"Cell"},{"key":"8397_CR13","doi-asserted-by":"crossref","unstructured":"Lan Z, Li X, Zhang X. Glioblastoma: an update in pathology, molecular mechanisms and biomarkers. Int J Mol Sci. 2024:25.","DOI":"10.3390\/ijms25053040"},{"key":"8397_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98\u2013110.","journal-title":"Cancer Cell"},{"key":"8397_CR15","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1038\/s41388-022-02295-w","volume":"41","author":"J Wu","year":"2022","unstructured":"Wu J, Shen S, Liu T, Ren X, Zhu C, Liang Q, et al. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. Oncogene. 2022;41:3024\u201336.","journal-title":"Oncogene"},{"key":"8397_CR16","doi-asserted-by":"crossref","unstructured":"Chanoch-Myers R, Wider A, Suva ML, Tirosh I. Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis. Genome Med. 2022:14.","DOI":"10.1186\/s13073-022-01109-8"},{"key":"8397_CR17","doi-asserted-by":"crossref","unstructured":"Kim Y, Varn FS, Park S-H, Yoon BW, Park HR, Lee C, et al. Perspective of mesenchymal transformation in glioblastoma. Acta Neuropathol Commun. 2021:9.","DOI":"10.1186\/s40478-021-01151-4"},{"key":"8397_CR18","first-page":"329","volume":"18","author":"KE Cahill","year":"2016","unstructured":"Cahill KE, Morshed RA, Yamini B. Nuclear factor-\u03baB in glioblastoma: insights into regulators and targeted therapy. Neurooncology. 2016;18:329\u201339.","journal-title":"Neurooncology"},{"key":"8397_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1101\/gad.183434.111","volume":"26","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S. NF-\u03baB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26:203\u201334.","journal-title":"Genes Dev"},{"key":"8397_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s43018-024-00780-7","volume":"5","author":"M De Palma","year":"2024","unstructured":"De Palma M, Hanahan D. Milestones in tumor vascularization and its therapeutic targeting. Nat Cancer. 2024;5:827\u201343.","journal-title":"Nat Cancer"},{"key":"8397_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41587-020-0550-z","volume":"38","author":"HH Caicedo","year":"2020","unstructured":"Caicedo HH, Hashimoto DA, Caicedo JC, Pentland A, Pisano GP. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:669\u201373.","journal-title":"Nat Biotechnol"},{"key":"8397_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang K-N, Wang Q, Li G, Zeng F, Zhang Y, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genom Proteom Bioinform. 2021;19:1\u201312.","journal-title":"Genom Proteom Bioinform"},{"key":"8397_CR23","doi-asserted-by":"publisher","first-page":"50349","DOI":"10.18632\/oncotarget.10387","volume":"7","author":"S Pinet","year":"2016","unstructured":"Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau M-O, et al. GlioVis data portal for visualization and analysis of brain tumor expression datasets. Oncotarget. 2016;7:50349\u201364.","journal-title":"Oncotarget"},{"key":"8397_CR24","doi-asserted-by":"crossref","unstructured":"Linderman GC, Zhao J, Kluger Y. Zero-preserving imputation of scRNA-seq data using low-rank approximation. 2018.","DOI":"10.1101\/397588"},{"key":"8397_CR25","doi-asserted-by":"crossref","unstructured":"Linderman GC, Zhao J, Roulis M, Bielecki P, Flavell RA, Nadler B, et al. Zero-preserving imputation of single-cell RNA-seq data. Nat Commun. 2022:13.","DOI":"10.1038\/s41467-021-27729-z"},{"key":"8397_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov Jill P, Tamayo P. The Molecular Signatures Database Hallmark Gene Set Collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"8397_CR27","doi-asserted-by":"crossref","unstructured":"Dimitrov D, T\u00fcrei D, Garrido-Rodriguez M, Burmedi PL, Nagai JS, Boys C, et al. Comparison of methods and resources for cell\u2013cell communication inference from single-cell RNA-Seq data. Nat Commun. 2022:13.","DOI":"10.1038\/s41467-022-30755-0"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08397-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:42:59Z","timestamp":1786592579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08397-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8397"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08397-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments involving patients were approved by the Ethics Committee of Zhujiang Hospital, Southern Medical University, and complied with the Declaration of Helsinki. Informed consent was not required because the data were analyzed anonymously. All animal experiments involved ethical and humane treatment under license from the Guangdong Provincial Bureau of Science (SMUL202404043).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1046"}}